| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pharmacology (W.B.D., J.G.S.) and Comparative Medicine (J.G.S.), University of South Alabama, College of Medicine, Mobile, Alabama 36688; and Department of Biochemistry and Molecular Biology (V.P., D.F.S.), Mayo Clinic Scottsdale, Scottsdale, Arizona 85259
Address all correspondence and requests for reprints to: Jonathan G. Scammell, Ph.D., Department of Pharmacology, MSB 3370, University of South Alabama, Mobile, Alabama 36688. E-mail: jscammel{at}jaguar1.usouthal.edu.
FK506-binding protein 51 (FKBP51) and FKBP52 are large molecular weight immunophilins that are part of the mature glucocorticoid receptor (GR) heterocomplex. These proteins possess peptidyl-prolyl isomerase (PPIase) and tetratricopeptide repeats (TPR) domains that are important for modulation of GR activity. A naturally occurring animal model of glucocorticoid resistance, the squirrel monkey, results from the relative overexpression of FKBP51 that renders the GR in a low-affinity state. In vitro studies demonstrated that the squirrel monkey form of FKBP51 is greater than 6-fold more potent than human FKBP51 in this respect. The goals of these studies were to determine the roles of the TPR and PPIase domains in the inhibitory activity of squirrel monkey FKBP51 and to gain insight into structural features of squirrel monkey FKBP51 responsible for potent inhibition of dexamethasone-stimulated GR activity. Mutations in the TPR of squirrel monkey FKBP51 that inhibit association with heat shock protein 90 blocked GR inhibitory activity. Mutations that abrogate the PPIase activity of squirrel monkey FKBP51 had no effect on GR inhibitory activity. Chimeras of squirrel monkey and human FKBP51 were tested to identify domains responsible for their different inhibitory potencies. Amino acid differences in domains FK1 and FK2 between squirrel monkey and human FKBP51 contribute equally to the enhanced inhibitory activity of squirrel monkey FKBP51. Furthermore, squirrel monkey FKBP51 in which either FK1 or FK2 was deleted lacked GR inhibitory activity. Thus, the potent inhibitory activity of squirrel monkey FKBP51 involves both FK domains and the heat shock protein 90-binding TPR domain.
This article has been cited by other articles:
![]() |
X. Zhang, A. F. Clark, and T. Yorio FK506-Binding Protein 51 Regulates Nuclear Transport of the Glucocorticoid Receptor {beta} and Glucocorticoid Responsiveness Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1037 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schlegel, O. Mirus, A. von Haeseler, and E. Schleiff The Tetratricopeptide Repeats of Receptors Involved in Protein Translocation across Membranes Mol. Biol. Evol., December 1, 2007; 24(12): 2763 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Woodruff, H. A. Boushey, G. M. Dolganov, C. S. Barker, Y. H. Yang, S. Donnelly, A. Ellwanger, S. S. Sidhu, T. P. Dao-Pick, C. Pantoja, et al. From the Cover: Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids PNAS, October 2, 2007; 104(40): 15858 - 15863. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, I. M. Wolf, H. Chen, S. Periyasamy, Z. Chen, W. Yong, S. Shi, W. Zhao, J. Xu, A. Srivastava, et al. FK506-Binding Protein 52 Is Essential to Uterine Reproductive Physiology Controlled by the Progesterone Receptor A Isoform Mol. Endocrinol., November 1, 2006; 20(11): 2682 - 2694. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Allan, D. Mok, B. K. Ward, and T. Ratajczak Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90: EVIDENCE THAT COUMARIN ANTIBIOTICS DISRUPT Hsp90 DIMERIZATION J. Biol. Chem., March 17, 2006; 281(11): 7161 - 7171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tranguch, J. Cheung-Flynn, T. Daikoku, V. Prapapanich, M. B. Cox, H. Xie, H. Wang, S. K. Das, D. F. Smith, and S. K. Dey From The Cover: Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation PNAS, October 4, 2005; 102(40): 14326 - 14331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |